Accueil>>Signaling Pathways>> Others>> Fluorescent Probes>>(+)-Biotin 4-Amidobenzoic Acid (sodium salt)

(+)-Biotin 4-Amidobenzoic Acid (sodium salt) (Synonyms: (+)-Biotin PABA, N-Biotinyl-4-aminobenzoic Acid)

Catalog No.GC45258

(+)-Biotin 4-amidobenzoic acid is a substrate of biotinidase, which cleaves biotin amide to give biotin in vivo.

Products are for research use only. Not for human use. We do not sell to patients.

(+)-Biotin 4-Amidobenzoic Acid (sodium salt) Chemical Structure

Cas No.: 102418-74-6

Taille Prix Stock Qté
5mg
43,00 $US
En stock
10mg
69,00 $US
En stock
25mg
150,00 $US
En stock
50mg
214,00 $US
En stock

Tel:(909) 407-4943 Email: sales@glpbio.com

Avis des clients

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

(+)-Biotin 4-amidobenzoic acid is a substrate of biotinidase, which cleaves biotin amide to give biotin in vivo. Biotin is an essential coenzyme for certain carboxylases and is used to modify histones and regulate gene transcription. Biotinidase has key roles in intestinal absorption of biotin, the transport of biotin in plasma, and in the regulation of histone biotinylation. (+)-Biotin 4-amidobenzoic acid is hydrolyzed by biotinidase to release 4-aminobenzoic acid (PABA), which can be quantified by either fluorescent or colorimetric methods. This approach is used in biotinidase activity assays in newborn screening protocols to evaluate biotinidase deficiency.

Avis

Review for (+)-Biotin 4-Amidobenzoic Acid (sodium salt)

Average Rating: 5 ★★★★★ (Based on Reviews and 27 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for (+)-Biotin 4-Amidobenzoic Acid (sodium salt)

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.